These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20085229)

  • 41. Potency and Sterility of Fortified Tobramycin, Fortified Vancomycin, and Moxifloxacin at 4, 24, and 35°C for 14 Days.
    Montes JA; Johnson D; Jorgensen J; McElmeel ML; Fulcher LC; Kiel JW
    Cornea; 2016 Jan; 35(1):122-6. PubMed ID: 26555587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generic benzalkonium chloride-preserved travoprost eye drops are not identical to the branded polyquarternium-1-preserved travoprost eye drop: Effect on cultured human conjunctival goblet cells and their physicochemical properties.
    Hedengran A; Freiberg JC; Hansen PM; Jacobsen J; Larsen SW; Harloff-Helleberg S; Freude K; Boix-Lemonche G; Petrovski G; Heegaard S; Kolko M
    Acta Ophthalmol; 2022 Nov; 100(7):819-827. PubMed ID: 35527390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Epinephrine stability in solutions for intra-ocular irrigations].
    Gairard AC; Demirdjian S; Vasseur R; Renard G; Chast F
    J Fr Ophtalmol; 1996; 19(12):743-7. PubMed ID: 9033898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [On the antimicrobial activity of benzalkonium chloride in potential contact lens fluids].
    Jira T; Panzig B; Pohloudek-Fabini R
    Pharmazie; 1982 Aug; 37(8):587-90. PubMed ID: 7146068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A method for the obtaining of increased viscosity eye drops containing amikacin.
    Sikora A; Oszczapowicz I; Tejchman B; Grzechnik M
    Acta Pol Pharm; 2005; 62(1):31-7. PubMed ID: 16022491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stability of self-prepared fortified antibiotic eyedrops.
    Lin CP; Tsai MC; Sun CY; Chen JY; Lin SR
    Kaohsiung J Med Sci; 1999 Feb; 15(2):80-6. PubMed ID: 10089717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Some studies on the preservation of indometacin suspensions intended for ophthalmic use.
    Vulovic N; Primorac M; Stupar M; Brown MW; Ford JL
    Pharmazie; 1990 Sep; 45(9):678-9. PubMed ID: 2284311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preservation of Biological Activity of Plasma and Platelet-Derived Eye Drops After Their Different Time and Temperature Conditions of Storage.
    Anitua E; de la Fuente M; Riestra A; Merayo-Lloves J; Muruzábal F; Orive G
    Cornea; 2015 Sep; 34(9):1144-8. PubMed ID: 26165790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biological Stability of Plasma Rich in Growth Factors Eye Drops After Storage of 3 Months.
    Anitua E; Muruzabal F; Pino A; Merayo-Lloves J; Orive G
    Cornea; 2013 Oct; 32(10):1380-6. PubMed ID: 23974892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Novel Method to Eliminate Preservatives in Eye Drops.
    Stanton D; Batich C; Schultz G; Gibson D; Guidi C; Yang Q; Bechtle A; Eiferman R
    J Ocul Pharmacol Ther; 2018 Oct; 34(8):584-589. PubMed ID: 30321108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Compatibility of a commercially available low-density polyethylene eye-drop container with antimicrobial preservatives and potassium ascorbate.
    Barnes AR
    J Clin Pharm Ther; 1995 Dec; 20(6):341-4. PubMed ID: 8847373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro compatibility study of cephalosporin with intraocular irrigating solutions and intracameral medications.
    Hui M; Lam PT; Cheung SW; Pang CP; Chan CY; Lam DS
    Clin Exp Ophthalmol; 2011 Mar; 39(2):164-70. PubMed ID: 20796261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microbial contamination of preservative free eye drops in multiple application containers.
    Rahman MQ; Tejwani D; Wilson JA; Butcher I; Ramaesh K
    Br J Ophthalmol; 2006 Feb; 90(2):139-41. PubMed ID: 16424520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alteplase as a catheter locking solution: in vitro evaluation of biochemical stability and antimicrobial properties.
    Weck S; Cheung S; Hiraoka-Sutow M; Patapoff T; Semba CP
    J Vasc Interv Radiol; 2005 Mar; 16(3):379-83. PubMed ID: 15758134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of topical ophthalmic In Situ gel-forming estradiol delivery system intended for the prevention of age-related cataracts.
    Kotreka UK; Davis VL; Adeyeye MC
    PLoS One; 2017; 12(2):e0172306. PubMed ID: 28222100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short- and Long-Term Stability of Plasma Rich in Growth Factors Eye Drops.
    Anitua E; de la Fuente M; Muruzábal F; Merayo-Lloves J
    Cornea; 2021 Jan; 40(1):107-112. PubMed ID: 32947409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microemulsions with timolol as potential eye drops.
    Malina I; Radomska-Soukharev A
    Pharmazie; 2006 Jul; 61(7):650-1. PubMed ID: 16889077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design and quality control of a pharmaceutical formulation containing natural products with antibacterial, antifungal and antioxidant properties.
    Ordoñez AA; Ordoñez RM; Zampini IC; Isla MI
    Int J Pharm; 2009 Aug; 378(1-2):51-8. PubMed ID: 19477252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Preservatives in eye drops: toward awareness of their toxicity].
    Vaede D; Baudouin C; Warnet JM; Brignole-Baudouin F
    J Fr Ophtalmol; 2010 Sep; 33(7):505-24. PubMed ID: 20832141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An in vitro study of the potency and stability of fortified ophthalmic antibiotic preparations.
    Bowe BE; Snyder JW; Eiferman RA
    Am J Ophthalmol; 1991 Jun; 111(6):686-9. PubMed ID: 1903903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.